Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer

HIGHLIGHTS

• who: B. B. M. Suelmann from the Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands have published the research work: Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer, in the Journal: (JOURNAL)
• what: This study assessed the genomic background of triple-negative PABC tumors by detection of alterations (CNAs). This study provides novel insights into the biology of triple-negative PABC tumors suggesting that CNAs particularly 8p loss and TOP2A loss are involved in the development of during FGFR1 loss and TOP2A loss seem to be promising . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.